期刊文献+

减重手术改善代谢的机制 被引量:4

Research progress in mechanisms by which bariatric surgery improves metabolism
原文传递
导出
摘要 减重手术是治疗肥胖及其合并症最有效的方法,但其机制目前仍未完全明确.除了手术的限容和促吸收不良作用以外,胃肠激素、胆汁酸、脂肪因子、肠道菌群和中枢神经系统的作用都可能是减重手术改善代谢的潜在机制.本文对此进行综述. Bariatric surgery is the most effective treatment for obesity and its comorbidities,but mechanisms of bariatric surgery remain unknown.In addition to volume restriction and malabsorption,gut hormones,bile acids,adipokines,intestinal microbiome and central nervous system may be the potential mechanisms.
出处 《中华胃肠外科杂志》 CAS CSCD 2014年第7期732-736,共5页 Chinese Journal of Gastrointestinal Surgery
关键词 肥胖 减重手术 机制 Obesity Bariatric Surgery Mechanism
  • 相关文献

参考文献69

  • 1Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [J]. JAMA, 2004,292: 1724-1737.
  • 2Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth- hormone-releasing acylated peptide from stomach [J]. Nature, 1999,402: 656-660.
  • 3Kirchner H, Gutierrez JA, Solenberg PJ, et al. GOAT links dietary lipids with the endocrine control of energy balance[J]. Nat Med, 2009,15:741-745.
  • 4Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans[J]. Diabetes, 2001,50: 1714-1719.
  • 5Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery [J]. N Engl J Med, 2002,346: 1623-1630.
  • 6Le Roux CW, Patterson M, Vincent RP, et al. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects [J]. J Clin Endocrinol Metab, 2005,90 : 1068-1071.
  • 7Zhao TJ, Liang G, Li RL, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice [J]. Proc Nail Acad Sci, 2010,107:7467-7472.
  • 8Stengel A, Tach~ Y. Ghrelin-a pleiotropic hormone secreted from endocrine X/A-like ceils of the stomach [J]. Front Neurosci, 2012,6 : 24.
  • 9Kirchner H, Tong J, TschSp M H, et al. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants [J]. Am J Physiol Endocrinol Metab, 2010,298 : E909-E919.
  • 10Barnett BP, Hwang Y, Taylor MS, et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor[J]. Science, 2010,330:1689-1692.

二级参考文献69

  • 1Hoist JJ. The physiology of glucagon-like peptide 1. Physiol Rev, 2007,87 : 1409 - 1439.
  • 2Stephens JW. The incretin system in the management of type 2 diabetes mellitus. Clin Med ,2010,10:491-495.
  • 3Reimann F, Habib AM, Tolhurst G, et al. Glucose sensing in L cells: a primary cell study. Cell Metab,2008 ,8 :532-539.
  • 4Cani PD,Holst JJ,Drucker DJ,et al. GLUT2 and the incretin re- ceptors are involved in glucose-induced incretin secretion. Mol Cell Endocrinol,2007,276 : 18-23.
  • 5Nielsen LB, Ploug KB, Swift P, et al. Co-localisation of the Kit6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in hu- man ileal cells and implications for glycaemic control in new onset type 1 diabetes. Eur J Endocrinol,2007,156:663-671.
  • 6E1-Ouaghlidi A,Rehring E, Hoist JJ, et al. The dipeptidyl pepti- dase 4 inhibitor vildagliptin does not accentuate glibenclamide-in- duced hypoglycemia but reduces glucose-induced glucagon-like pep|ide L and gastric inhibitory polypeptide secretion. J Clin Endocrinol Metab ,2007,92:4165-4171.
  • 7Murphy R, Tura A, Clark PM, et al. Glucokinase, the pancreatic glucose sensor,is not the gut glucose sensor. Diabetologia,2009, 52:154-159.
  • 8Pearson ER,Flechtner I, Njolstad PR, et al. Switching from insu- lin to oral sulfonylureas in patients with diabetes due Io Kit6.2 mutations. N Engl J Med,2006,355:467-477.
  • 9Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab, 2009,297: EI358-E1365.
  • 10Wright EM, Hirayama BA, Loo DF. Active sugar transport in heath and disease. J Intern Med,2007,261:32-43.

共引文献47

同被引文献32

  • 1刘云,张唯力,胡丽娜,徐晓阳.女性内分泌和性功能关系的研究[J].中国性科学,2005,14(5):10-11. 被引量:2
  • 2辛虹,李瑞珍,王振海.女性性功能障碍分类及危险因素[J].国外医学(计划生育.生殖健康分册),2006,25(6):327-329. 被引量:2
  • 3Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey [J]. Ann Surg, 2004,240 (2) : 205-213.
  • 4Lee JH, Park dJ, Kim HH, et al. Comparison of complications af- ter laparoscopy-assistcd distal gastrectomy and open distal gastrcc- tomy for gastric cancer using the Clavien-Dindo classification[ J]. Surg Endosc, 2012,26 ( 5 ) : 1287-1295. DOI: 10. 1007/s00464- 011-2027-0.
  • 5Braga M, Capretti G, Pecorelli N, et al. A prognostic score to predict major complications after pancreaticoduodenectomy [ J ]. Ann Surg, 2011, 254 ( 5 ) : 702-708. DOI: 10. 1097/SLA. 0b013e31823598fb.
  • 6E1 Nakeeb A, Hamed H, Shehta A, et al. Impact of obesity on surgical outcomes post-pancreaticoduodenectomy: a case-control study[ J]. Int J Surg,2014,12(5 ) :488-493. DOI: 10. 1016/j. ij- su. 2014.01. 017.
  • 7Li Q, Zhang J, Zhou Y, et al. Obesity and gastric cancer [ J]. Front Biosci ( Landmark Ed) ,2012,17:2383-2390.
  • 8Bickenbach KA, Denton B, Gonen M, et al. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer[ J ]. Ann Surg Oncol,2013,20 (3) :780-787. DOI : 10. 1245/s10434-012-2653-3.
  • 9Roberts KJ, Hodson J, Mehrzad H, et al. A preoperative predic- tive score of pancreatic fistula following pancreatoduodenectomy [J]. HPB (Oxford),2014,16(7):620-628. DOI:10. 1111/ hpb. 12186.
  • 10Ramacciato G, Mercantini P, Petrucciani N, et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review[J]. Am Surg,2011,77 (3) :257-269.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部